🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

437,23 USD

Máx. histórico

447,03

10 días

Split 2:1 del 22/11/1999

Caída desde máximo

-2,19%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-1,55%

Cierre anterior

444,12

Rango de hoy

435,01 – 441,66

Volumen hoy

1.656.089

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
27,17 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 3 días
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,27%
Fecha de pago Importe por participación
16/11/2022 1,9400 USD
17/08/2022 1,9400 USD
16/05/2022 1,9400 USD
14/02/2022 1,9400 USD
15/11/2021 1,7600 USD
16/08/2021 1,7600 USD
14/05/2021 1,7600 USD
11/02/2021 1,7600 USD
13/11/2020 1,6000 USD
14/08/2020 1,6000 USD
15/05/2020 1,6000 USD
13/02/2020 1,6000 USD
14/11/2019 1,4500 USD
14/08/2019 1,4500 USD
16/05/2019 1,4500 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/08/2009 61,13 61,58 59,99 60,85 -0,02% 2,60% 12.948.000
13/08/2009 62,26 64,76 60,61 60,86 -2,09% 6,67% 20.751.000
12/08/2009 62,71 62,80 61,77 62,16 -1,03% 1,64% 9.858.700
11/08/2009 61,02 62,98 60,46 62,81 +2,56% 4,13% 15.446.300
10/08/2009 60,47 61,33 59,79 61,24 +1,24% 2,55% 6.725.500
07/08/2009 61,55 61,59 59,97 60,49 -0,33% 2,63% 8.677.100
06/08/2009 62,42 62,46 60,64 60,69 -2,60% 2,92% 8.894.800
05/08/2009 63,66 63,83 62,01 62,31 -3,26% 2,86% 7.095.200
04/08/2009 62,14 64,43 62,12 64,41 +2,43% 3,72% 11.739.200
03/08/2009 62,42 62,98 61,71 62,88 +0,91% 2,03% 7.138.400
31/07/2009 63,04 63,61 62,00 62,31 -1,27% 2,55% 6.361.100
30/07/2009 63,67 64,50 62,99 63,11 -0,19% 2,37% 9.855.700
29/07/2009 62,62 63,50 62,36 63,23 +1,30% 1,82% 11.811.900
28/07/2009 62,71 62,84 61,42 62,42 +2,72% 2,26% 18.802.100
27/07/2009 61,01 61,50 59,78 60,77 -0,25% 2,82% 10.946.800
24/07/2009 59,20 61,00 59,20 60,92 +1,80% 3,04% 6.773.900
23/07/2009 58,44 59,97 58,04 59,84 +2,52% 3,30% 10.015.300
22/07/2009 58,60 59,11 58,02 58,37 -0,44% 1,86% 5.492.900
21/07/2009 58,67 58,93 58,11 58,63 +0,62% 1,40% 6.782.300
20/07/2009 58,58 58,90 57,79 58,27 -0,88% 1,89% 7.191.400
17/07/2009 58,80 59,00 58,00 58,79 +0,55% 1,70% 7.929.100
16/07/2009 57,91 59,82 57,51 58,47 +1,04% 3,99% 12.186.900
15/07/2009 58,36 58,38 57,24 57,87 -0,40% 1,95% 10.237.400
14/07/2009 57,90 58,78 57,83 58,10 +0,16% 1,64% 8.520.600
13/07/2009 58,03 58,22 57,15 58,01 +0,35% 1,84% 11.954.800
10/07/2009 57,62 58,76 57,38 57,81 -0,55% 2,40% 8.609.500
09/07/2009 59,03 59,29 57,54 58,13 -2,30% 2,96% 16.209.600
08/07/2009 60,25 60,95 59,38 59,50 +13,92% 2,61% 50.037.100
07/07/2009 51,91 52,96 51,61 52,23 +0,35% 2,60% 10.105.700
06/07/2009 51,19 52,18 50,65 52,05 +1,13% 2,99% 7.246.100